Skip to main content

Catalio Capital Management — Portfolio, Page 3

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

139
Companies
$11.4B
Total invested
$82.0M
Avg. check
22
Industries
Biotechnology 17Health Care 15Medical 13Life Science 8Pharmaceutical 7Therapeutics 7+16 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 49–72 of 139
Perceive Pharma
February 2025

Perceive Pharma operates as a pharmaceutical company.

Life Science · San Francisco$15.0M Series A
DNA Script
February 2025

DNA Script is a disruptive DNA synthesis company harnessing biology to accelerate breakthroughs in life science and human health.

Biotechnology · Le Kremlin-bicêtre$4.7M Grant
PinkDx
January 2025

PinkDx is a biotechnology company.

Biopharma · Indianapolis$5.0M Series A
Aviceda Therapeutics
January 2025

Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.

Biotechnology · Cambridge$207.5M Series C
Medical Informatics
January 2025

Medical Informatics offers solutions that give care teams access to the data they need to take action for alarm management and safety.

Health Care · Houston$5.0M Debt Financing
Sentonix
January 2025

Sentonix is a pharmaceutical company that offers immuno-therapy service for cancer treatment.

Biopharma · ArlingtonSeed
Alentis Therapeutics
November 2024

ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.

Biotechnology · Allschwil$181.4M Series D
Sunbird Bio
October 2024

Sunbird Bio is a diagnostics platform developer that aims to give molecular diagnostics with faster outcomes.

Biotechnology · Singapore$14.0M Venture - Series Unknown
Orasis Pharmaceuticals
October 2024

Orasis Pharmaceuticals is an ophthalmic pharmaceutical company that develops eye drops for the treatment of presbyopia.

Clinical Trials · Ponte Vedra$68.0M Series D
Noetik
September 2024

Noetik is an AI-native biotechnology company that applies machine learning to large-scale human multimodal spatial omics datasets.

Artificial Intelligence (AI) · South San Francisco$1.0M Grant
EGenesis
September 2024

EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases.

Biopharma · Cambridge$191.0M Series D
Elektrofi
August 2024

Elektrofi is a preclinical-stage company dedicated to redefining the standard of drug delivery by transforming the patient experience.

Alternative Medicine · Boston$112.3M Series C
Axena Health
June 2024

Axena Health develops commercial-stage medical devices for women's pelvic health.

Health Care · Newton$9.4M Series A
Cage Pharma
May 2024

Cage Pharma is a pre-clinical biopharmaceutical company that develops new drugs targeting the metabolism of tumors.

Biopharma · Baltimore$137K Venture - Series Unknown
Neumora Therapeutics
April 2024

Neumora Therapeutics operates as a clinical-stage biotechnology company.

Biotechnology · Watertown$2.6M Grant
Clasp Therapeutics
March 2024

Clasp Therapeutics offers to reach of immuno-oncology with novel precision medicines that enable the immune system.

Biotechnology · Cambridge$150.0M Series A
Roshal Imaging Services
February 2024

Roshal Imaging Services is a provider of on-site and portable diagnostic Vascular and General body (OB/Gyn) ultrasound services.

Health Care · Katy$10.0M Venture - Series Unknown
NextPoint Therapeutics
February 2024

NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.

Biotechnology · Cambridge$42.5M Series B
Volta Labs
January 2024

Volta Labs develops scalable automation for genetic engineering.

Biometrics · CambridgeVenture - Series Unknown
OnCusp Therapeutics
January 2024

OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments.

Biotechnology · New York$100.0M Series A
Lassen Therapeutics
December 2023

Lassen Therapeutics develops antibody biotherapeutics to help improve the lives of patients suffering from serious diseases.

Biotechnology · San Diego$85.0M Series B
Sanguine
October 2023

Bridging the gap between patients and researchers

Apps · Woburn$6.0M Debt Financing
Centenara Labs
September 2023

Centenara Labs is an integrated biotechnology platform company that invests in people and ideas to develop therapies.

Biotechnology · SchlierenDebt Financing
TapestryHealth
August 2023

TapestryHealth provides telemedicine services including primary care, emergency care, and various health screenings.

Assisted Living · Stratford$25.0M Debt Financing

Where Catalio Capital Management invests

Biotechnology17
Health Care15
Medical13
Life Science8
Pharmaceutical7
Therapeutics7

About Catalio Capital Management's portfolio

How many companies has Catalio Capital Management invested in?▸

Catalio Capital Management has invested in 139 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Catalio Capital Management invest in?▸

Catalio Capital Management's top investment sectors include Biotechnology, Health Care, Medical, Life Science, Pharmaceutical. The firm invests across 22 different industry categories.

What is Catalio Capital Management's largest investment?▸

Among tracked funding rounds, Aviceda Therapeutics received $207.5M in a Series C round. Catalio Capital Management's total known invested capital is $11.4B.

What is the average investment size for Catalio Capital Management?▸

Catalio Capital Management's average investment size is $82.0M across its portfolio of 139 companies.

What are Catalio Capital Management's most recent investments?▸

Recent Catalio Capital Management portfolio additions include Perceive Pharma, DNA Script, PinkDx, Aviceda Therapeutics, Medical Informatics. These companies were founded in 2020 or later.

Reach the founders behind these 139 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →